A phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherapy administered to adult patients with moderate-to-severe atopic dermatitis

(PI: Rice, co-I: Chen) 1% effort 2 subjects

Awarded By

  • Regeneron

Contributors

Amount

  • $21,207.00

Start/End

  • June 1, 2015 - 2017